We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Biohm Technologies Stock

Invest in or calculate the value of your shares in Biohm Technologies or other pre-IPO companies through EquityZen's platform.

Get Started

Biohm Technologies Stock

Biohm Technologies analyzes and manages the gut's total microbiome via consultations, tests, and consumer products.

About Biohm Technologies Stock

Founded

2016

Headquarters

Cleveland, OH, US

Industries

Software, Artificial Intelligence, Data and Analytics

Biohm Technologies is the first microbiome company to address the critical role of fungi in digestive health. The company offers a selection of whole probiotics and gut microbiome testing. After over 20 years of research supported by the National Institutes of Health (NIH), Dr. Ghannoum’s work on the microbiome has converged into one of the biggest discoveries in digestive health. The discovery is how bad bacteria and bad fungus work together to create digestive plaque. This destructive film protects bad bacteria and bad fungi as they work to upset the balance of your digestive system. His solution marked the dawning of a new generation of probiotics with dual-action technology that first breaks open digestive plaque, and then neutralizes the bad bacteria and bad fungi, which allows the gut to maintain its natural microbiome balance, ultimately supporting optimal digestive health.

Biohm Technologies Management

Leadership team at Biohm Technologies

CEO

Afif Ghannoum

Locked Features

Join now and verify your accreditation status to gain access to:

  • Biohm Technologies Current Valuation
  • Biohm Technologies Stock Price
  • Biohm Technologies Management
  • Available deals in Biohm Technologies and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Biohm Technologies Cap Table and Funding History by Share Class and Liquidity Preferences
    • Biohm Technologies Revenue and Financials
    • Biohm Technologies Highlights
    • Biohm Technologies Business Model
    • Biohm Technologies Risk Factors
  • Biohm Technologies Research Report from SACRA Research
Join Now

Trading Biohm Technologies Stock

How to invest in Biohm Technologies stock?

Accredited investors can buy pre-IPO stock in companies like Biohm Technologies through EquityZen funds. These investments are made available by existing Biohm Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Biohm Technologies stock?

Shareholders can sell their Biohm Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Biohm Technologies